Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.44

€0.44

3.320%
0.014
3.320%
-
 
24.04.24 / Frankfurt WKN: A12EBR / Name: DBV Technologies / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

DBV Technologies S.A. ADR Stock

A very strong showing by DBV Technologies S.A. ADR today, with an increase of €0.014 (3.320%) compared to yesterday's price.

Pros and Cons of DBV Technologies S.A. ADR in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-13

The financials of DBV Technologies, a company in the pharmaceutical industry, provide a mixed impression. On one hand, the company shows potential for growth, backed by a significant increase in total assets between 2020 and 2022. However, it is impossible to overlook the consistently negative net income throughout the reported period.

Increase in Total Assets: DBV Technologies has experienced a substantial increase in its total assets, from $146.7 million in 2021 to $246.5 million in 2022. This growth suggests the company's capability to accumulate and manage resources for potential expansion and business ventures.

Decrease in Total Liabilities: The company has shown a decline in total liabilities, decreasing from $66.8 million in 2020 to $52 million in 2022, indicating a better financial position and ability to manage obligations.